2026-06-30 2026, Volume 4 Issue 3

  • Select all
  • Review article
    Parwinder Kaur, Amanpreet Kaur, Rimpi

    One potential method for improving transdermal medication absorption is ionic liquids (ILs). However, further research is necessary to create effective ILs and clarify their methods of action because of the unique structural characteristics of ILs. This paper examines the basic design concepts of ideal ILs for transdermal drug delivery systems (TDDS), taking into account toxicity, skin permeability, and melting point, all of which are influenced by ion types, molar ratios, functional groups, and inter-ionic interactions. The functions of ILs in developing TDDS are also described in detail, including their use as novel solvents to improve drug solubility in carriers, as innovative skin penetration enhancers to increase transdermal drug absorption, as new active pharmaceutical ingredients (API-ILs) to control drug pharmacokinetics, skin permeability, solubility, and release, and as sophisticated polymers to develop smart medical materials. Additionally, a summary of several action pathways is provided, mainly focusing on the interactions between ILs, medications, polymers, and skin constituents. The discussion concludes with a discussion of ILs' future challenges, including determining quantitative structure-activity relationships, comprehending the intricate forces of interaction between anions, medications, polymers, and the skin microenvironment, guaranteeing long-term stability, and resolving in vivo safety issues. In conclusion, the purpose of this essay is to encourage the development of TDDS with ILs.

  • Full length article
    Xin-ling Liu, Ling Li, Xiao-ye Cao, Jia-ying Tu, Bo Yuan

    Objective: This study aimed to assess workflow changes and identify optimization strategies following the implementation of a wireless communication-based intelligent drug dispensing and traceability system (IDDTS) in an inpatient pharmacy setting, with the goal of improving operational efficiency and the accuracy of medication order processing and dispensing.

    Methods: A pre–post observational study was conducted over two consecutive 30-working-day periods before and after IDDTS implementation to document changes in the medication order dispensing workflow. User Journey Mapping and Root Cause Analysis were employed to investigate potential causes of the low utilization of the IDDTS for processing one-time medication orders. Based on the findings, the workflow for one-time medication orders was redesigned and optimized. The effectiveness of these interventions was evaluated by comparing key performance indicators before and after the process reconstruction.

    Results: The implementation of the IDDTS, together with workflow redesign and optimization, reduced redundant steps and improved medication order dispensing performance, including workflow efficiency and dispensing accuracy. Utilization of the system for one-time medication orders and overall staff satisfaction also improved.

    Conclusions: The IDDTS shows considerable potential to streamline inpatient pharmacy dispensing operations and support workflow optimization for medication order processing and distribution. Further refinements are recommended to fully realize its benefits in routine practice.

  • Review article
    Juan Wu, Yawen Yuan, Haonan Li, Junyu Li, Cheng Jin

    Children, as a special population, exhibit significant age-specific characteristics and inter-individual variability in drug metabolism due to the influences of physiological development and genetic factors, bringing challenges to the efficacy and safety of clinical medication. Traditional pharmacokinetic studies are difficult to conduct in children and are constrained by numerous ethical limitations. Physiologically based pharmacokinetic (PBPK) modeling, as a mechanistic modeling tool, can integrate pediatric developmental physiological parameters, enzyme kinetic characteristics, and genetic polymorphism data. It has gradually become an important tool for predicting pediatric drug metabolism and optimizing dosing regimens. This review summarizes the key enzymatic characteristics of pediatric drug metabolism and the technological pathways and current application status of PBPK models in assessing pediatric drug metabolism. It discusses the major challenges, such as uncertainties in parameter extrapolation and the lack of pediatric-specific data. It further elaborates on the practical value of PBPK models in optimizing dosing regimens, supporting pediatric clinical trial design, and aiding regulatory decision-making. Finally, it proposes future directions for development by integrating artificial intelligence and multi-omics data. This review aims to provide a theoretical basis and practical reference for precision dosing in children and to promote the broader application of PBPK models in the pediatric pharmaceutical field.

  • Full length article
    Xintong Liu, Qiong Gu, Xiaoan Feng, Linlin Fan, Jing Xu, Chunyu Li, Guohui Li

    Purpose: To investigate the active components and mechanisms of Qizao Baoxin Formula (QBF) in improving trastuzumab-induced cardiotoxicity (TIC) via ferroptosis regulation using network pharmacology and molecular docking.

    Methods: The components of QBF were got from TCMSP 2.0, Herb 2.0, SymMap 2.0, ETCM 2.0, and BATMAN-TCM 2.0 five traditional Chinese medicine databases and screened using SwissADME. Targets were obtained from TCMSP and SwissTargetPrediction. Targets related to TIC were got from GeneCards, PubMed, and the Gene Expression Omnibus (GSE264120). Targets related to ferroptosis were obtained from FerrDb. Venny was applied to obtain the intersection targets. The Protein-Protein Interaction was constucted to investigate protein interactions and identify core targets. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were made to explore functions and pathways. A “Chinese Medicine-Component-Target” network was made to identify core components. Molecular docking was performed to validate interactions.

    Results: A total of 1,690 QBF-related targets, 856 TIC-related targets, and 969 targets related to ferroptosis were identified, yielding 52 intersection targets. PPI network analysis identified 25 core targets, including BCL2, HIF1A, NFE2L2, and more. Enrichment analysis revealed significant involvement in oxidative stress, the FoxO signaling pathway, and more. The “Chinese Medicine-Component-Target” network analysis identified 268 core components, six main components of which exhibited strong binding affinity to BCL2, HIF1A, and NFE2L2.

    Conclusions: QBF may target BCL2, HIF1A, and NFE2L2 via its core components to regulate oxidative stress, modulate ferroptosis, and alleviate TIC. These findings provide a scientific basis for further experimentation investigating QBF-mediated modulation of ferroptosis in TIC treatment.

  • Review article
    Xi Chen, Pengfei Jin, Haiyan Mai, Shuhong Liang, Yaodong Ping, Chen Wang, Yingbo Zhao

    The integration of artificial intelligence (AI) into healthcare is reshaping medical disciplines, with hospital pharmacy undergoing a significant paradigm shift from a labor-intensive model to an intelligence-driven one. This comprehensive review examines the transformative role of AI in pharmaceutical administration and clinical pharmacy, synthesizing recent advancements, identifying key challenges, and projecting future directions. In pharmacy management, AI optimizes procurement through intelligent platforms, enhances dispensing accuracy and safety via automated systems and robotic technologies, and revolutionizes pharmacovigilance by shifting from spontaneous reporting to proactive, data-driven signal detection using machine learning (ML) and natural language processing (NLP). In clinical practice, AI-powered clinical decision support systems (AI-CDSS) augment clinician judgment by enabling real-time data analysis and improving therapeutic outcomes, while human-AI collaborative pre-prescription review systems significantly enhance medication safety. Furthermore, AI facilitates personalized medicine through the integration of pharmacogenomics and leverages large language models(LLMs) to improve patient engagement and medication adherence. Crucially, this review argues that AI is not a replacement for pharmacists but a catalyst for redefining their professional roles, elevating them from dispensers to clinical decision-makers and multidisciplinary collaborators. Despite its vast potential, the widespread adoption of AI faces significant hurdles, including poor data quality and interoperability, algorithmic “black-box” issues that undermine trust, ethical and privacy concerns, lagging regulatory frameworks, and a lack of long-term economic validation. Looking ahead, the future of intelligent pharmacy will be shaped by the integration of LLMs with knowledge graphs, the rise of explainable AI (XAI), the implementation of federated learning for secure data sharing, and the establishment of end-to-end digital ecosystems. Ultimately, AI is poised to become an indispensable collaborator in pharmacy, fostering a more efficient, intelligent, and patient-centered ecosystem.

  • Full length article
    Chang You, Yan Shen

    Background: Standardized residency training (SRT) is a core component of postgraduate medical education, and its quality is closely linked to residents' clinical performance. Currently, research on residents' post competency in China is limited, with a lack of comprehensive evaluation standards.

    Objectives: To establish a competency-based evaluation index system for SRT and verify its effectiveness in predicting training outcomes.

    Methods: This study integrated literature analysis, expert survey, and analytic hierarchy process (AHP) to construct the evaluation index system. AHP was used for weight assignment, with MATLAB software calculating indicator weights. Questionnaire surveys were conducted among residents from four departments for empirical validation, and t-test (SPSS 23.0) was used for statistical analysis.

    Results: The index system included 5 first-level and 24 second-level indicators. The consistency ratio of AHP was 0.0201 (<0.1), confirming reasonable weight assignment, with "Competency improvement" having the highest weight (0.3852). T-test results showed no statistically significant differences between predicted and actual scores(all P > 0.05), and expert satisfaction was above 9.0.

    Conclusions: The constructed index system is scientific and practical, effectively predicting SRT outcomes, and can provide a basis for optimizing residency training models.

  • Full length article
    Hao Wang, Yuelin Huang, Yongfen Ding, Min Min, Haoran Li, Ruolan Zhang, Suyang Ma, Haoxiang Li, Xinrui Men, Liqun Yu

    Objective: To investigate the therapeutic mechanism of Huoxue Quyu San Reyan Bao in treating sequelae of pelvic inflammatory disease (SPID) using network pharmacology and molecular docking.

    Methods: Active components and targets of Huoxue Quyu San were obtained from TCMSP, HERB, and UniProt. SPID-related targets were retrieved from GeneCards and OMIM. Common targets were identified via Venny 2.1.0, and a herb-component-target-pathway-disease network was constructed using Cytoscape 3.10.0. A PPI network was built using STRING to screen core targets. GO and KEGG enrichment analyses were performed using DAVID. Molecular docking was conducted using AutoDock Vina 1.5.7 to validate binding affinities.

    Results: A total of 170 active components and 154 common targets were identified. Key components included quercetin, apigenin, baicalein, luteolin, and daidzein. Core targets were AKT1, TNF, IL-6, INS, IL-1β, and TP53. Involved pathways included cancer, TNF, PI3K-Akt, AGE-RAGE in diabetic complications, IL-17, lipid/atherosclerosis, C-type lectin receptor, and fluid shear stress/atherosclerosis pathways. Molecular docking showed strong binding affinities.

    Conclusions: Huoxue Quyu San treats SPID by modulating TNF, PI3K-Akt, and AGE-RAGE pathways, exerting anti-inflammatory, antioxidant, microcirculation-improving, and apoptosis-inducing effects.

Publishing model
0

{"submissionFirstDecision":"19","jcrJfStr":"-"}

Downloads

Submission to first decision (median)
19 days

ISSN 2949-866X (Print)